Related Experiment Videos
[Dermatomycoses relevant to general practice and their treatment]
Wiener Medizinische Wochenschrift (1946)
|August 31, 1989
Summary
Dermatomycoses, fungal skin infections, are increasingly affecting children. Selecting broad-spectrum antifungals like Ciclopiroxolamine or Griseofulvin, potentially combined with topical treatments, improves outcomes and reduces relapse rates.
Area of Science:
- Dermatology
- Mycology
- Pharmacology
Background:
- Dermatomycoses represent a significant category of dermatological conditions.
- There is a notable rise in pediatric and adolescent cases.
- Effective treatment necessitates careful selection of antimycotic agents.
Observation:
- Broad-spectrum antifungals with high activity and good tolerability, such as Ciclopiroxolamine, are crucial for therapeutic success.
- For deep-seated or extensive dermatophytoses, Griseofulvin is indicated.
- Combination therapy involving Griseofulvin and topical antifungals may offer benefits.
Findings:
- The choice of antimycotic agent directly impacts treatment efficacy.
- Ciclopiroxolamine demonstrates broad-spectrum activity and good tolerability.
- Griseofulvin is effective for severe dermatophytosis cases.
Implications:
- Optimizing antifungal selection can lead to better patient outcomes in dermatomycoses.
- Combination therapies may reduce treatment duration and relapse frequency.
- Further research into pediatric dermatomycoses treatment is warranted.